A novel adjuvant therapeutic material: Chemoprevention of monascus-fermented product on oral cancer

Medicine & Life Sciences

• monascin 73%
• Mouth Neoplasms 63%
• Fungi 45%
• ankaflavin 44%
• Dioscorea 44%
• Cricetinae 44%
• Oryza 43%
• Paintings 38%
• Lovastatin 28%
• Carcinogenesis 22%
• Neoplasms 18%
• Ethanol 18%
• Psychological Inhibition 11%
• benz(a)anthracene 11%
• Growth 10%
• Anti-Inflammatory Agents 10%
• Matrix Metalloproteinase 7 10%
• CDC2 Protein Kinase 10%
• Germination 10%
• Cyclin B1 9%
• Therapeutics 9%
• 3-hydroxy-3-methylglutaryl-coenzyme A 9%
• RAW 264.7 Cells 9%
• Far East 8%
• Angiogenesis Inhibitors 8%
• Cell Line 8%
• G2 Phase 8%
• Prostaglandin-Endoperoxide Synthases 7%
• Chinese Traditional Medicine 7%
• Nitric Oxide Synthase Type II 7%
• Tobacco Use 7%
• Interleukin-1 7%
• Dinoprostone 7%
• Tumor Burden 6%
• Cell Division 6%
• Alcohol Drinking 6%
• Oxidoreductases 6%
• Vascular Endothelial Growth Factor A 6%
• Lipopolysaccharides 6%
• Mouth 6%
• Squamous Cell Carcinoma 6%
• Therapeutic Uses 5%
• Nitric Oxide 5%
• Colon 5%
• Reactive Oxygen Species 5%
• Adenocarcinoma 5%
• Animal Models 5%
• Macrophages 5%

Chemical Compounds

• Adjuvant 71%
• Buccal 69%
• Red 39%
• Ethanol 18%
• Antiinflammatory 18%
• Citrinin 15%
• Metabolite 13%
• Prostaglandin E2 13%
• Coenzyme A 11%
• Lipopolysaccharide 10%
• Anthracene 9%
• Nitric Oxide 9%
• Reactive Oxygen Metabolite 9%
• Cholesterol 8%
• Biosynthesis 8%
• Metabolic 7%
• Antioxidant Agent 7%
• Alcohol 5%
• Drug 5%